Community-based care for the management of type 2 diabetes: an evidence-based analysis.

Oct 18, 2012Ontario health technology assessment series

Using community care to manage type 2 diabetes: a review of the evidence

AI simplified

Abstract

Specialized multidisciplinary community care may reduce glycosylated hemoglobin (HbA1c) levels by 1.05% compared to usual care.

  • Moderate quality evidence supports that specialized community care involving a pharmacist and physician leads to a significant reduction in HbA1c levels.
  • The effect of this model on systolic blood pressure (SBP) shows a reduction of 7.13 mm Hg based on moderate quality evidence.
  • Model 1, which includes a nurse, dietician, and physician, also shows a reduction in HbA1c by 1.00%, but the SBP effect is uncertain, with very-low quality evidence.
  • Both care models do not indicate a preferred setting for delivering care, such as primary care or community clinics.

AI simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free